Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07144761

Evaluating Patient Reported Outcomes and Surgeon Satisfaction With Ziplyft™

The objective of this study is to evaluate patient-reported outcomes, surgeon reported outcomes, bruising, symmetry, the success of tissue adhesive for wound closure, and case time.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Blepharoplasty

Age range

35 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Center for Excellence in Eye Care, Miami, Florida, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Provide signed written consent prior to participation in any study-related procedures.
  • Ability, comprehension, and willingness to follow study instructions, and likely to complete all study visits.
  • Male or female adults, ≥ 35 years old at the Preoperative Visit
  • Willing to return for required follow-up visits.
  • Subjects with excess eyelid skin are eligible to undergo the procedure in the opinion of the investigator.
  • Female subjects must be 1-year postmenopausal, surgically sterilized, or, if of childbearing potential, have a negative urine pregnancy test at the Preoperative Visit. Women of childbearing potential must use an acceptable form of contraception throughout the study. Acceptable methods include at least one of the following: intrauterine (intrauterine device), hormonal (oral, injection, patch, implant, ring), barrier with spermicide (condom, diaphragm), or abstinence.

Exclusion criteria

  • Subjects with a current Ptosis diagnosis
  • Subjects with a history of Graves' Disease
  • Subjects with Myasthenia Gravis
  • Subjects that in the opinion of the investigator are anatomically not conducive to using devices (e.g., heavy brow, severe hollowing of the upper eyelid, history of ocular or orbital trauma).
  • Subjects that have had any previous surgery eyelid or eyebrow region.
  • Use of anticoagulation therapy, including, but not limited to Aspirin, NSAIDS, Ibuprofen within 7 days and Xarelto, Warfarin, Enoxaparin, Plavix within 3 days prior to planned study procedure.
  • Active or recent (within 3 months) tobacco user
  • Allergy to adhesive glue
  • Participation in any study of an investigational, interventional product within 30 days prior to the Preoperative Visit or at any time during the study period.
  • Pregnant or nursing females.

Treatment and study plan

Ziplyft

Device

Ziplyft™ is a Class 1, 510(k) Exempt device for removing excess unwanted eyelid skin using a novel surgical device called Ziplyft™.

Primary outcomes

  1. Improvement in overall patient satisfaction - Satisfaction with facial appearance and eyes

    Time frame: From enrollment to the last visit at 3 months

    Demonstrate an improvement in overall patient satisfaction by comparing pre-operative and post-operative patient reported outcome scores.

    FACE-Q - Aesthetics - Appearance - Satisfaction with facial appearance FACE-Q - Aesthetics - Appearance - Satisfaction with Eyes

    On a scale of 1-4 Very Dissatisfied being 1 and Very Satisfied being 4

  2. Surgeon Satisfaction and Efficiency

    Time frame: From enrollment to the last visit at 3 months.

    Demonstrate surgeon satisfaction and efficiency with Ziplyft™, measured by Surgeon Satisfaction Survey with questions focused on ease of procedure, patient tolerance, device useability, surgical technique, procedural time, wound closure, need for suture, ease of achieving symmetry, device placement on the lid crease, cutting mechanism, seal of the zipper-locked tissue, surgical time and evaluating for post-operative complications with 5 being better outcome and 1 being worse.

  3. Improvement in Eye Age

    Time frame: From enrollment to the last visit at 3 months.

    Demonstrate improvement in Eye Age and Face Age after the Ziplyft™ procedure.

    FACE-Q - Aesthetics - Appearance - Aging Appraisal On a scale of 1-4, with 1 being Definitely Disagree and 4 being Definitely agree

  4. Measure the success of tissue adhesive for wound closure.

    Time frame: From enrollment to the last visit at 3 months.

    Measuring the success of the tissue adhesive involves evaluating the following: Visual inspection, Adhesion strength and adherence, and Patient satisfaction. Questions added in the patient satisfaction survey about comfort of glue, ease of blinking, aesthetically acceptable with 1 being a worse outcome and 4 being better.

  5. Post-operative ecchymosis

    Time frame: From enrollment to the last visit at 3 months.

    Document post-operative ecchymosis with Ziplyft. Measured by post-operative photographs.

  6. Eyelid Symmetry

    Time frame: From enrollment to the last visit at 3 months.

    To achieve optimal eyelid symmetry after eyelid surgery with Ziplyft™ by independent reviewers' assessments.

    Measurement of symmetry will be judged on a scale of 1-4 by an independent reviewer based on post-op patient photos. 1 being worse and 4 being better outcome.

  7. Improved case time

    Time frame: From enrollment to last visit at 3 months.

    Demonstrate improved case time with Ziplyft™

Study contacts

Contact information is provided by the study sponsor or research team.

Becky Weathers

CONTACT

[email protected]

541-312-4622

Patricia Buehler, MD

CONTACT

[email protected]

541-419-4412

Sponsors and collaborators

Lead sponsor

Osheru Inc.

Industry

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Aug 27, 2025
Registry last updated
Aug 27, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.